Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,462
Total Claims
$639K
Drug Cost
462
Beneficiaries
$1,384
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+56%
Opioid rate vs peers
4.0% vs 2.6% avg
+30%
Cost per patient vs peers
$1,384 vs $1,068 avg
+45%
Brand preference vs peers
13.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.0%
Opioid Rate
420
Opioid Claims
$7,664
Opioid Cost
5.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,357 claims · $434K
Generic: 9,055 claims · $202K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 217 | $96K |
| Rivaroxaban | 40 | $33K |
| Dulaglutide | 19 | $29K |
| Insulin Aspart | 26 | $24K |
| Insulin Detemir | 24 | $21K |
| Fluticasone/Umeclidin/Vilanter | 19 | $18K |
| Sitagliptin Phosphate | 11 | $13K |
| Insulin Degludec | 18 | $12K |
| Mirabegron | 33 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $9,782 |
| Potassium Chloride | 382 | $8,123 |
| Pregabalin | 123 | $6,940 |
| Insulin Glargine,hum.Rec.Anlog | 11 | $6,715 |
| Umeclidinium Brm/Vilanterol Tr | 13 | $5,650 |
| Diclofenac Sodium | 141 | $5,544 |
Prescribing Profile
Patient Profile
81
Avg Age
76%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About